HB0417 — Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
Last action — Committee Report (House of Origin) — Favorable with Amendments
-
1Introduced
-
2In Committee
-
3Passed House of Delegates
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill has been introduced in the House of Delegates. Introduced January 22, 2026. It must pass committee before a floor vote.
Next likely step: a committee referral and hearing.
Odds of enactment
Low chanceBased on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
-
Introduced
Current position in the legislative process.
-
21 sponsors
1 primary, 20 co-sponsors signed on.
-
Bipartisan support
Sponsored across 2 parties (13 D · 5 R) — cross-party backing.
-
Cleared a recorded vote
Passed 1 recorded vote so far.
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
Summary
Establishing medetomidine and xylazine as Schedule III controlled dangerous substances under the Maryland Controlled Dangerous Substances Act
Bill Text
We don't have the full text on file for this bill yet.
Read HB0417 on the official Maryland source →Action History
-
Committee Report (House of Origin) — Favorable with Amendments
-
Third Reading (House of Origin) — Passed
-
First Reading (Opposite House)
-
Second Reading (House of Origin) — Passed with Amendments
-
Hearing (Primary, House of Origin)
-
First Reading (House of Origin)
Sponsors
- Delegate Jesse T. Pippy · Primary
- Delegate Kenneth Kerr · Cosponsor
- Delegate Tiffany T. Alston · Cosponsor
- Delegate Heather Bagnall · Cosponsor
- Delegate Bonnie Cullison · Cosponsor
- Delegate Pam Lanman Guzzone · Cosponsor
- Delegate Terri L. Hill · Cosponsor
- Delegate Thomas S. Hutchinson · Cosponsor
- S. Johnson · Cosponsor
- Delegate Aaron M. Kaufman · Cosponsor
- Delegate Nicholaus R. Kipke · Cosponsor
- Delegate Lesley J. Lopez · Cosponsor
- Delegate Ashanti Martinez · Cosponsor
- M. Morgan · Cosponsor
- Delegate Teresa E. Reilly · Cosponsor
- Delegate Samuel I. Rosenberg · Cosponsor
- Delegate Kim Ross · Cosponsor
- Delegate Kathy Szeliga · Cosponsor
- Delegate Deni Taveras · Cosponsor
- White Holland · Cosponsor
- Delegate Teresa Woorman · Cosponsor
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 20 co-sponsors · 167 not signed on
Sponsors (1)
- Delegate Jesse T. Pippy Republican
Co-sponsors (20)
- Delegate Kenneth Kerr Democrat
- Delegate Tiffany T. Alston Democrat
- Delegate Heather Bagnall Democrat
- Delegate Bonnie Cullison Democrat
- Delegate Pam Lanman Guzzone Democrat
- Delegate Terri L. Hill Democrat
- Delegate Thomas S. Hutchinson Republican
- Johnson, S.
- Delegate Aaron M. Kaufman Democrat
- Delegate Nicholaus R. Kipke Republican
- Delegate Lesley J. Lopez Democrat
- Delegate Ashanti Martinez Democrat
- Morgan, M.
- Delegate Teresa E. Reilly Republican
- Delegate Samuel I. Rosenberg Democrat
- Delegate Kim Ross Democrat
- Delegate Kathy Szeliga Republican
- Delegate Deni Taveras Democrat
- White Holland
- Delegate Teresa Woorman Democrat
Not signed on (167)
167 members have not signed on to this bill.
Show all 167 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Votes
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 11 | 0 | 0 | 3 |
| Democrat | 85 | 0 | 0 | 8 |
| Republican | 31 | 0 | 0 | 3 |
| Total | 127 | 0 | 0 | 14 |
| % of votes cast | 90% | 0% | 0% | 10% |
How each member voted (141)
Subjects
Frequently asked questions
- What does HB0417 do?
- Establishing medetomidine and xylazine as Schedule III controlled dangerous substances under the Maryland Controlled Dangerous Substances Act
- Who sponsors HB0417?
- HB0417 is sponsored by Delegate Jesse T. Pippy (Republican), Delegate Kenneth Kerr (Democrat), Delegate Tiffany T. Alston (Democrat), Delegate Heather Bagnall (Democrat), Delegate Bonnie Cullison (Democrat), Delegate Pam Lanman Guzzone (Democrat), Delegate Terri L. Hill (Democrat), Delegate Thomas S. Hutchinson (Republican), Johnson, S., Delegate Aaron M. Kaufman (Democrat), Delegate Nicholaus R. Kipke (Republican), Delegate Lesley J. Lopez (Democrat), Delegate Ashanti Martinez (Democrat), Morgan, M., Delegate Teresa E. Reilly (Republican), Delegate Samuel I. Rosenberg (Democrat), Delegate Kim Ross (Democrat), Delegate Kathy Szeliga (Republican), Delegate Deni Taveras (Democrat), White Holland, and Delegate Teresa Woorman (Democrat).
- What is the current status of HB0417?
- This bill has been introduced in the House of Delegates. Introduced January 22, 2026. It must pass committee before a floor vote.
- Where can I track HB0417?
- Track HB0417 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB0417
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB0417
Last checked for changes about 1 hour ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →